[Solid cystic papillary tumor of pancreas in children---a report of eight cases with literature review].
OBJECTIVE
Solid cystic papillary tumor (SCPT) of the pancreas in children is rare with limited references of its clinical features and treatment. Therefore, to estimate the clinicopathologic features of SCPT of the pancreas in children is necessary.


METHODS
Clinical data of 8 children with pathologically confirmed SCPT of the pancreas, treated from 2000 to 2005 with surgery, were analyzed retrospectively. The clinicopathologic features were analyzed with literature review.


RESULTS
All patients were girls but one, with the average age of 12.8 years. The chief complaints were burbulence, abdominal pain, and palpable mass. The tumors were mainly located in the head or tail of the pancreas. Of the 8 patients, 1 received local resection, 5 received distal pancreatectomy, 1 received pancreatico-duodenectomy, and 1 received only biopsy. Seven patients were followed-up for 2 months to 4 years and were still alive; 2 patients suffered recurrence. All cases showed solid with cystic areas and papillary protrusions. Immunohistochemically, the positive rates were 100% for alpha-antitrypsin, 87.5% for vinmentin, and 62.5% for neuron-specific enolase.


CONCLUSIONS
SCPT of the pancreas occurs predominantly in young girls, and its pathogenesis is still unknown. Surgical resection is usually curative, and the prognosis is good.
Zhang
Ke-Ren
KR
Department of Pediatric Surgery, The Second Affiliated Hospital, China Medical University, Shenyang, Liaoning 110004, P. R. China. zkr425@yahoo.com
Jia
Hui-Min
HM
Shu
Hong
H
Li
Xin-Yuan
XY
D000293:Adolescent; D002648:Child; D018292:Cystadenoma, Papillary / Q000737:chemistry / Q000473:pathology / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000737:chemistry / Q000473:pathology / Q000601:surgery; D010751:Phosphopyruvate Hydratase / Q000032:analysis; D011379:Prognosis; D012189:Retrospective Studies; D014746:Vimentin / Q000032:analysis; D000515:alpha 1-Antitrypsin / Q000032:analysis
D014746:Vimentin; D000515:alpha 1-Antitrypsin; D010751:Phosphopyruvate Hydratase